By the end of 2018, through 10 years of continuous research and development, we have successfully developed : Small molecule targeted anti-tumor products: 21 projects ,such as Gefitinib, Erlotinib, Pazopanib, Lapatinib, Afatinib, Lenvatinib,etc; Diabetes products: 16 items ,such as Sitagliptin, Linagliptin,Alogliptin, Dapagliflozin, and Canagliflozin,etc; Anti-Cardiovascular products: 7 projects ,including Apixaban, Rivaroxaban, Betrixaban, and Dofetilide;
ANQING CHICO PHARMACEUTICAL CO.,LTD.
Country: 
China (Mainland)
Business Type: Trading Company
Premiumsupplier
Ms.JIANG
Tel: +86-13057662806
2-Amino-5-methoxy-4-(phenylmethoxy)-benzoic acidCAS NO.: 155666-33-4
6-Methoxy-7-benzyloxyquinazolin-4-oneCAS NO.: 179688-01-8
7-(Benzyloxy)-4-(4-bromo-2-fluoroanilino)-6-methoxyquinazolineCAS NO.: 768350-54-5
6-Methoxy-7-hydroxyquinazolin-4-oneCAS NO.: 162012-72-8
4-[[(4-Tolylsulfonyl)oxy]methyl]piperidine-1-carboxylic acid tert-butyl esterCAS NO.: 166815-96-9
4-Chloro-7-[N-methylpiperidin-4-ylmethoxy]-6-methoxyquinazolineCAS NO.: 264208-72-2
6-Methoxy-7-(N-methylpiperidin-4-ylmethoxy)-3,4-dihydroquinazolin-4-oneCAS NO.: 264208-69-7
(5-bromo-2-chlorophenyl)(4-fluorophenyl)methanoneCAS NO.: 915095-85-1
2-Brom-5-chlorbenzoesureCAS NO.: 21739-93-5
5-BromosalicylaldehydeCAS NO.: 1761-61-1
